Xenon Pharmaceuticals Inc. (XENE) stock
XENENasdaqPharmaceutical PreparationsFiscal year ends December 31
$37.75−1.03 (-2.66%)
Close on Nov 18, 2026Market cap $3.66BP/E –Yield –
Xenon Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Xenon Pharmaceuticals's market cap was $4.07B on Nov 11, 2026, against $3.45B a year earlier. Over the last 5 years it ranged from $1.12B to $6.06B, with a median of $2.92B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $4.07B | +17.8% |
| 2025 | Dec 31, 2025 | $3.46B | +16.3% |
| 2024 | Dec 31, 2024 | $2.97B | -0.8% |
| 2023 | Dec 29, 2023 | $2.99B | +21.4% |
| 2022 | Dec 30, 2022 | $2.47B | +90.6% |
| 2021 | Dec 31, 2021 | $1.29B | +140.4% |
| 2020 | Dec 31, 2020 | $538.22M | +58.7% |
| 2019 | Dec 31, 2019 | $339.14M | +113.4% |
| 2018 | Dec 31, 2018 | $158.93M | +212.6% |
| 2017 | Dec 29, 2017 | $50.85M | -63.1% |
| 2016 | Dec 30, 2016 | $137.78M | +19.5% |
| 2015 | Dec 31, 2015 | $115.33M | +332.7% |
| 2014 | Dec 31, 2014 | $26.65M | – |
See a number that looks wrong?